BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang X, Bai L, Han C, Qi X. Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma. Cancer Manag Res 2020;12:2839-51. [PMID: 32425598 DOI: 10.2147/CMAR.S244381] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Shibusawa M, Kusumi E, Murakami J, Tanimoto T. Response-Adapted Postinduction Strategy in Follicular Lymphoma. J Clin Oncol 2022;:JCO2102818. [PMID: 35275704 DOI: 10.1200/JCO.21.02818] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cao X, Wang Y, Li P, Huang W, Lu X, Lu H. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Front Oncol 2021;11:685706. [PMID: 34277431 DOI: 10.3389/fonc.2021.685706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Xu YQ, Chen W, Shen HY, Dong SL, Li J, Li KR, Li ZY, Zhu F, Xu KL. [The clinical characteristics and viral reactivation in B cell non-Hodgkin's lymphoma patients with hepatitis B virus infection]. Zhonghua Xue Ye Xue Za Zhi 2021;42:514-7. [PMID: 34384160 DOI: 10.3760/cma.j.issn.0253-2727.2021.06.013] [Reference Citation Analysis]